Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcus Biosciences, Inc.RCUS · Entity 4104 | 10% owner | March 19, 2018 | March 19, 2018 |
| Care.com IncCRCM · Entity 11923 | 10% owner | December 29, 2019 | December 30, 2019 |
| CrowdStrike Holdings, Inc.CRWD · Entity 1172 | 10% owner | February 20, 2020 | February 25, 2020 |
| Duolingo, Inc.DUOL · Entity 3679 | 10% owner | July 13, 2022 | July 15, 2022 |
| Freshworks Inc.FRSH · Entity 2193 | 10% owner | August 20, 2024 | August 30, 2024 |
| Gitlab Inc.GTLB · Entity 3663 | Member of 10% Group | May 05, 2023 | May 09, 2023 |
| Oscar Health, Inc.OSCR · Entity 3582 | 10% owner | August 17, 2023 | August 21, 2023 |
| Planet Labs PBCPL · Entity 3716 | 10% owner | December 07, 2021 | December 17, 2021 |
| Prime Medicine, Inc.PRME · Entity 5281 | 10% owner | August 01, 2025 | August 05, 2025 |
| Spero Therapeutics, Inc.SPRO · Entity 7014 | 10% owner | November 01, 2017 | November 01, 2017 |
| Starco Brands, Inc.STCB · Entity 7537 | 10% owner | May 15, 2025 | May 19, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcus Biosciences, Inc.
Report date March 19, 2018 · Filed March 19, 2018
Jointly reported with GV 2016 GP, L.L.C., GV 2016 GP, L.P., GV 2016, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GV 2016, L.P. | 3,125,312 |
Reported balance
After 2018-03-19 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-03-19 · Conversion · Acquired 3,125,312 · Balance 3,125,312 F1: The total represents shares received upon conversion of shares of Series B Convertible Preferred Stock. F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F2: The reported security is directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
| Series B Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy GV 2016, L.P. | 0 |
Reported balance
After 2018-03-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-03-19 · Conversion · Disposed 3,125,312 · Balance 0 F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F2: The reported security is directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The total represents shares received upon conversion of shares of Series B Convertible Preferred Stock.
F2: The reported security is directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Care.com Inc
Report date December 29, 2019 · Filed December 30, 2019
Jointly reported with CapitalG LP, CapitalG GP LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Convertible Preferred Stock, Series ASEC Table II · derivative / convertible security · Conversion / exercise price $10.50 | IndirectSee Footnote | 46,350 |
Reported balance
After 2019-12-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-12-29 · Other · Acquired 0 · Balance 46,350 F1: The Convertible Preferred Stock, Series A, par value $0.001 per share (the "Convertible Preferred Stock"), is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Convertible Preferred Stock into Common Stock (i) at any time after the seventh anniversary of June 29, 2016 (the "Closing Date"), and (ii) between the fifth anniversary and the seventh anniversary of the Closing Date, if certain conditions are met. F2: Holders of the Convertible Preferred Stock are entitled to cumulative dividends, whether or not declared by the Issuer's board of directors, at the rate of 5.50% per annum during the period from the Closing Date to the seventh anniversary of the Closing Date. Such dividends are payable semi-annually in arrears on June 29 and December 29 of each year, by increasing the liquidation preference of each share of Convertible Preferred Stock. Accordingly, the liquidation preference of each share of Convertible Preferred Stock increased on December 29, 2019, such that the number of shares of Convertible Preferred Stock held directly by CapitalG LP remained the same, but are now convertible into 5,325,981 shares of Common Stock. F3: CapitalG LP directly holds shares of the Convertible Preferred Stock. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have the sole power to vote and dispose of these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the Convertible Preferred Stock, except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The Convertible Preferred Stock, Series A, par value $0.001 per share (the "Convertible Preferred Stock"), is convertible at any time and has no expiration date. The Issuer may mandatorily convert the Convertible Preferred Stock into Common Stock (i) at any time after the seventh anniversary of June 29, 2016 (the "Closing Date"), and (ii) between the fifth anniversary and the seventh anniversary of the Closing Date, if certain conditions are met.
F2: Holders of the Convertible Preferred Stock are entitled to cumulative dividends, whether or not declared by the Issuer's board of directors, at the rate of 5.50% per annum during the period from the Closing Date to the seventh anniversary of the Closing Date. Such dividends are payable semi-annually in arrears on June 29 and December 29 of each year, by increasing the liquidation preference of each share of Convertible Preferred Stock. Accordingly, the liquidation preference of each share of Convertible Preferred Stock increased on December 29, 2019, such that the number of shares of Convertible Preferred Stock held directly by CapitalG LP remained the same, but are now convertible into 5,325,981 shares of Common Stock.
F3: CapitalG LP directly holds shares of the Convertible Preferred Stock. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have the sole power to vote and dispose of these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the Convertible Preferred Stock, except to the extent of any pecuniary interest therein.
CrowdStrike Holdings, Inc.
Report date February 20, 2020 · Filed February 25, 2020
Jointly reported with CapitalG LP, CapitalG GP LLC, CapitalG 2015 LP, CapitalG 2015 GP LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 82,488 |
Reported balance
After 2020-02-20 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2020-02-20 · Conversion · Acquired 82,488 · Balance 82,488 F1: Shares of Class B Common Stock automatically converted into shares of Class A Common Stock effective immediately prior to the sale of such shares. F3: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2020-02-20 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2020-02-20 · Sale · Disposed 82,488 · Balance 0 F2: Weighted average sale price for Class A Common Stock sold. Actual sales price for shares sold ranged from $65.00 to $65.96. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price. F3: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 140,000 |
Reported balance
Holding disclosure · report date 2020-02-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 140,000 F4: These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 1,137,641 |
Reported balance
After 2020-02-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-02-20 · Conversion · Disposed 82,488 · Balance 1,137,641 F5: The Class B Common Stock is convertible into the Issuer's Class A Common Stock on a one-for-one basis upon (i) the affirmative written election of the holder thereof or (ii) the occurrence of a transfer, except for certain transfers described in the Issuer's amended and restated certificate of incorporation (the "Restated Certificate") and has no expiration date. F6: In addition, Class B Common Stock will automatically convert into Class A Common Stock on the earliest of (i) the date specified by the holders of two-thirds of the then outstanding shares of Class B Common Stock, (ii) the date on which the number of outstanding shares of Class B Common Stock represents less than 5% of the number of outstanding shares of Class A Common Stock and Class B Common Stock, taken together as a single class, which calculation excludes certain Acquisition Securities, as defined in the Restated Certificate, and (iii) the date that is nine months after the death or permanent and total disability of the Issuer's founder, George Kurtz, provided that such date may be extended by a majority of the independent members of the Issuer's board of directors to a date that is not longer than 18 months from the date of such death or disability. F7: This total includes 100,000 shares of Class B Common Stock that, due to an administrative error, were inadvertently omitted from Column 9 of the Form 4 filed by the Reporting Persons on February 19, 2020. F3: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 8,133,626 |
Reported balance
Holding disclosure · report date 2020-02-20 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 8,133,626 F5: The Class B Common Stock is convertible into the Issuer's Class A Common Stock on a one-for-one basis upon (i) the affirmative written election of the holder thereof or (ii) the occurrence of a transfer, except for certain transfers described in the Issuer's amended and restated certificate of incorporation (the "Restated Certificate") and has no expiration date. F6: In addition, Class B Common Stock will automatically convert into Class A Common Stock on the earliest of (i) the date specified by the holders of two-thirds of the then outstanding shares of Class B Common Stock, (ii) the date on which the number of outstanding shares of Class B Common Stock represents less than 5% of the number of outstanding shares of Class A Common Stock and Class B Common Stock, taken together as a single class, which calculation excludes certain Acquisition Securities, as defined in the Restated Certificate, and (iii) the date that is nine months after the death or permanent and total disability of the Issuer's founder, George Kurtz, provided that such date may be extended by a majority of the independent members of the Issuer's board of directors to a date that is not longer than 18 months from the date of such death or disability. F4: These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Class B Common Stock automatically converted into shares of Class A Common Stock effective immediately prior to the sale of such shares.
F2: Weighted average sale price for Class A Common Stock sold. Actual sales price for shares sold ranged from $65.00 to $65.96. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.
F3: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F4: These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F5: The Class B Common Stock is convertible into the Issuer's Class A Common Stock on a one-for-one basis upon (i) the affirmative written election of the holder thereof or (ii) the occurrence of a transfer, except for certain transfers described in the Issuer's amended and restated certificate of incorporation (the "Restated Certificate") and has no expiration date.
F6: In addition, Class B Common Stock will automatically convert into Class A Common Stock on the earliest of (i) the date specified by the holders of two-thirds of the then outstanding shares of Class B Common Stock, (ii) the date on which the number of outstanding shares of Class B Common Stock represents less than 5% of the number of outstanding shares of Class A Common Stock and Class B Common Stock, taken together as a single class, which calculation excludes certain Acquisition Securities, as defined in the Restated Certificate, and (iii) the date that is nine months after the death or permanent and total disability of the Issuer's founder, George Kurtz, provided that such date may be extended by a majority of the independent members of the Issuer's board of directors to a date that is not longer than 18 months from the date of such death or disability.
F7: This total includes 100,000 shares of Class B Common Stock that, due to an administrative error, were inadvertently omitted from Column 9 of the Form 4 filed by the Reporting Persons on February 19, 2020.
Duolingo, Inc.
Report date July 13, 2022 · Filed July 15, 2022
Jointly reported with CapitalG 2014 LP, Alphabet Holdings LLC, CapitalG II GP LLC, CapitalG II LP, CapitalG 2015 GP LLC, CapitalG 2015 LP, CapitalG 2014 GP LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 578,755 |
Reported balance
After 2022-07-13 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2022-07-13 · Conversion · Acquired 500,000 · Balance 578,755 F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock in connection with: (i) any transfer, whether or not for value, except for certain permitted transfers further described in the Issuer's amended and restated certificate of incorporation and (ii) such time as the aggregate number of shares of Class B Common Stock outstanding ceases to represent 5% of the aggregate number of shares of Common Stock outstanding. F2: Shares held by CapitalG 2014 LP. CapitalG 2014 GP LLC, the general partner of CapitalG 2014 LP, Alphabet Holdings LLC, the managing member of CapitalG 2014 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2014 LP. F3: Each of CapitalG 2014 GP LLC, CapitalG 2015 GP LLC, CapitalG II GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 65,689 |
Reported balance
Holding disclosure · report date 2022-07-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 65,689 F3: Each of CapitalG 2014 GP LLC, CapitalG 2015 GP LLC, CapitalG II GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F4: Shares held by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2015 LP. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 445,920 |
Reported balance
After 2022-07-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-07-13 · Conversion · Disposed 500,000 · Balance 445,920 F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock in connection with: (i) any transfer, whether or not for value, except for certain permitted transfers further described in the Issuer's amended and restated certificate of incorporation and (ii) such time as the aggregate number of shares of Class B Common Stock outstanding ceases to represent 5% of the aggregate number of shares of Common Stock outstanding. F2: Shares held by CapitalG 2014 LP. CapitalG 2014 GP LLC, the general partner of CapitalG 2014 LP, Alphabet Holdings LLC, the managing member of CapitalG 2014 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2014 LP. F3: Each of CapitalG 2014 GP LLC, CapitalG 2015 GP LLC, CapitalG II GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 789,001 |
Reported balance
Holding disclosure · report date 2022-07-13 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 789,001 F6: No transaction is being reported. The holding of such shares by the reporting person was previously reported. F3: Each of CapitalG 2014 GP LLC, CapitalG 2015 GP LLC, CapitalG II GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F4: Shares held by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2015 LP. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 758,146 |
Reported balance
Holding disclosure · report date 2022-07-13 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 758,146 F6: No transaction is being reported. The holding of such shares by the reporting person was previously reported. F3: Each of CapitalG 2014 GP LLC, CapitalG 2015 GP LLC, CapitalG II GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F5: Shares held by CapitalG II LP. CapitalG II GP LLC, the general partner of CapitalG II LP, Alphabet Holdings LLC, the managing member of CapitalG II GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG II LP. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock in connection with: (i) any transfer, whether or not for value, except for certain permitted transfers further described in the Issuer's amended and restated certificate of incorporation and (ii) such time as the aggregate number of shares of Class B Common Stock outstanding ceases to represent 5% of the aggregate number of shares of Common Stock outstanding.
F2: Shares held by CapitalG 2014 LP. CapitalG 2014 GP LLC, the general partner of CapitalG 2014 LP, Alphabet Holdings LLC, the managing member of CapitalG 2014 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2014 LP.
F3: Each of CapitalG 2014 GP LLC, CapitalG 2015 GP LLC, CapitalG II GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F4: Shares held by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2015 LP.
F5: Shares held by CapitalG II LP. CapitalG II GP LLC, the general partner of CapitalG II LP, Alphabet Holdings LLC, the managing member of CapitalG II GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG II LP.
F6: No transaction is being reported. The holding of such shares by the reporting person was previously reported.
Freshworks Inc.
Report date August 20, 2024 · Filed August 30, 2024
Jointly reported with CapitalG 2014 LP, Alphabet Holdings LLC, CapitalG 2013 GP LLC, CapitalG 2013 LP, CapitalG 2014 GP LLC, CapitalG GP LLC, CapitalG II GP LLC, CapitalG II LP, CapitalG LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 1,941,391 |
Reported balance
Holding disclosure · report date 2024-08-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,941,391 F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F2: Shares held by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG LP. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 1,879,370 |
Reported balance
Holding disclosure · report date 2024-08-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,879,370 F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F3: Shares held by CapitalG II LP. CapitalG II GP LLC, the general partner of CapitalG II LP, Alphabet Holdings LLC, the managing member of CapitalG II GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG II LP. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 4,726,247 |
Reported balance
Holding disclosure · report date 2024-08-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,726,247 F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F4: Shares held by CapitalG 2013 LP. CapitalG 2013 GP LLC, the general partner of CapitalG 2013 LP, Alphabet Holdings LLC, the managing member of CapitalG 2013 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2013 LP. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 3,789,635 |
Reported balance
Holding disclosure · report date 2024-08-20 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,789,635 F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F5: Shares held by CapitalG 2014 LP. CapitalG 2014 GP LLC, the general partner of CapitalG 2014 LP, Alphabet Holdings LLC, the managing member of CapitalG 2014 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2014 LP. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 3,870,000 |
Reported balance
Holding disclosure · report date 2024-08-20 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 3,870,000 F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F6: Shares held by CapitalG IV LP. CapitalG IV GP LLC, the general partner of CapitalG IV LP, Alphabet Holdings LLC, the managing member of CapitalG IV GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG IV LP. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2024-08-20 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F7: Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F3: Shares held by CapitalG II LP. CapitalG II GP LLC, the general partner of CapitalG II LP, Alphabet Holdings LLC, the managing member of CapitalG II GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG II LP. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2024-08-20 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance Not disclosed F7: Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F4: Shares held by CapitalG 2013 LP. CapitalG 2013 GP LLC, the general partner of CapitalG 2013 LP, Alphabet Holdings LLC, the managing member of CapitalG 2013 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2013 LP. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2024-08-20 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance Not disclosed F7: Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. F5: Shares held by CapitalG 2014 LP. CapitalG 2014 GP LLC, the general partner of CapitalG 2014 LP, Alphabet Holdings LLC, the managing member of CapitalG 2014 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2014 LP. |
Filing footnotes · ownership attribution and instrument terms
F1: Each of CapitalG LP, CapitalG II, LP, CapitalG 2013 LP, CapitalG 2014 LP, CapitalG IV LP, CapitalG 2013 GP LLC, CapitalG 2014 GP LLC, CapitalG IV GP LLC, CapitalG GP II LLC, CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F2: Shares held by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG LP.
F3: Shares held by CapitalG II LP. CapitalG II GP LLC, the general partner of CapitalG II LP, Alphabet Holdings LLC, the managing member of CapitalG II GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG II LP.
F4: Shares held by CapitalG 2013 LP. CapitalG 2013 GP LLC, the general partner of CapitalG 2013 LP, Alphabet Holdings LLC, the managing member of CapitalG 2013 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2013 LP.
F5: Shares held by CapitalG 2014 LP. CapitalG 2014 GP LLC, the general partner of CapitalG 2014 LP, Alphabet Holdings LLC, the managing member of CapitalG 2014 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG 2014 LP.
F6: Shares held by CapitalG IV LP. CapitalG IV GP LLC, the general partner of CapitalG IV LP, Alphabet Holdings LLC, the managing member of CapitalG IV GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to the shares held directly by CapitalG IV LP.
F7: Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.
Gitlab Inc.
Report date May 05, 2023 · Filed May 09, 2023
Jointly reported with GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy GV 2021, L.P. | 2,647,312 |
Reported balance
After 2023-05-05 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-05-05 · Purchase · Acquired 7,286 · Balance 2,647,312 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.86 to $27.00, inclusive. The reporting persons undertake to provide to GitLab Inc., any security holder of GitLab Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 of this Form 4. F2: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "Partnership"). GV 2021 GP, L.P. (the "GP") is the general partner of the Partnership. GV 2021 GP, L.L.C. ("GV 2021 LLC") is the general partner of the GP. Alphabet Holdings LLC ("Alphabet Holdings") is the sole member of GV 2021 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the GP, GV 2021 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the securities directly beneficially owned by the Partnership. Each of the GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.86 to $27.00, inclusive. The reporting persons undertake to provide to GitLab Inc., any security holder of GitLab Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 of this Form 4.
F2: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "Partnership"). GV 2021 GP, L.P. (the "GP") is the general partner of the Partnership. GV 2021 GP, L.L.C. ("GV 2021 LLC") is the general partner of the GP. Alphabet Holdings LLC ("Alphabet Holdings") is the sole member of GV 2021 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the GP, GV 2021 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the securities directly beneficially owned by the Partnership. Each of the GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Oscar Health, Inc.
Report date August 17, 2023 · Filed August 21, 2023
Jointly reported with Alphabet Holdings LLC, CapitalG 2015 LP, CapitalG 2015 GP LLC, CapitalG LP, CapitalG GP LLC, GV 2014 GP, L.L.C., GV 2014, L.P., Verily Life Sciences LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 15,625,310 |
Reported balance
After 2023-08-17 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2023-08-17 · Sale · Disposed 5,719,438 · Balance 15,625,310 F1: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F2: These shares are owned directly by Alphabet Holdings LLC. XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,180,474 |
Reported balance
After 2023-08-17 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2023-08-17 · Sale · Disposed 525,470 · Balance 1,180,474 F1: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F3: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2023-08-17 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2023-08-17 · Sale · Disposed 255,092 · Balance 0 F1: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F4: These shares are owned directly by Verily Life Sciences LLC. OB Technology Holdings Inc., the managing member of Verily Life Sciences LLC, XXVI Holdings Inc., the managing member of OB Technology Holdings Inc., and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of OB Technology Holdings Inc., XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 255,092 |
Reported balance
Holding disclosure · report date 2023-08-17 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 255,092 F5: These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 481,988 |
Reported balance
Holding disclosure · report date 2023-08-17 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 481,988 F6: These shares are owned directly by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the managing member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period.
F2: These shares are owned directly by Alphabet Holdings LLC. XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F3: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F4: These shares are owned directly by Verily Life Sciences LLC. OB Technology Holdings Inc., the managing member of Verily Life Sciences LLC, XXVI Holdings Inc., the managing member of OB Technology Holdings Inc., and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of OB Technology Holdings Inc., XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F5: These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F6: These shares are owned directly by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the managing member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
Planet Labs PBC
Report date December 07, 2021 · Filed December 17, 2021
Jointly reported with Google LLC, XXVI Holdings Inc.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 31,942,641 |
Reported balance
Holding disclosure · report date 2021-12-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 31,942,641 F1: Shares held directly by Google LLC. Each of Google LLC, XXVI Holdings Inc. (the managing member of Google LLC) and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may be deemed to have sole power to vote or sole power to dispose of the securities held directly by Google LLC. Each of XXVI Holdings Inc. and Alphabet Inc. may be deemed an indirect beneficial owner of the reported securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held directly by Google LLC. Each of Google LLC, XXVI Holdings Inc. (the managing member of Google LLC) and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may be deemed to have sole power to vote or sole power to dispose of the securities held directly by Google LLC. Each of XXVI Holdings Inc. and Alphabet Inc. may be deemed an indirect beneficial owner of the reported securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.
Prime Medicine, Inc.
Report date August 01, 2025 · Filed August 05, 2025
Jointly reported with GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GV 2021, L.P. | 3,262,440 |
Reported balance
After 2025-08-01 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-08-01 · Purchase · Acquired 1,500,000 · Balance 3,262,440 F1: Represents shares purchased in connection with an underwritten public offering of the Issuer's Common Stock that closed on August 1, 2025. F2: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "2021 Partnership"). The general partner of the 2021 Partnership is GV 2021 GP, L.P. (the "2021 GP"). The general partner of the 2021 GP is GV 2021 GP, L.L.C. ("GV 2021 LLC"). The sole member of GV 2021 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the securities directly beneficially owned by the 2021 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares purchased in connection with an underwritten public offering of the Issuer's Common Stock that closed on August 1, 2025.
F2: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "2021 Partnership"). The general partner of the 2021 Partnership is GV 2021 GP, L.P. (the "2021 GP"). The general partner of the 2021 GP is GV 2021 GP, L.L.C. ("GV 2021 LLC"). The sole member of GV 2021 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the securities directly beneficially owned by the 2021 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Spero Therapeutics, Inc.
Report date November 01, 2017 · Filed November 01, 2017
Jointly reported with GV 2015 GP, L.L.C., GV 2015, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectBy GV 2015, L.P. | Not disclosed |
Reported balance
Holding disclosure · report date 2017-11-01 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The shares of Series C preferred stock beneficially owned by the Reporting Persons are convertible into the number of shares of common stock shown in Column 3 at any time at the holder's election and automatically convert immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date. F2: Share numbers give effect to the 1-for-6.0774 reverse stock split of the Issuer's common stock effected on October 20, 2017. F3: The shares are directly held by GV 2015, L.P. GV 2015 GP, L.L.C., the general partner of GV 2015, L.P., Alphabet Holdings LLC, the sole member of GV 2015 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote and dispose of these shares. Each of GV 2015 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Series C preferred stock beneficially owned by the Reporting Persons are convertible into the number of shares of common stock shown in Column 3 at any time at the holder's election and automatically convert immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F2: Share numbers give effect to the 1-for-6.0774 reverse stock split of the Issuer's common stock effected on October 20, 2017.
F3: The shares are directly held by GV 2015, L.P. GV 2015 GP, L.L.C., the general partner of GV 2015, L.P., Alphabet Holdings LLC, the sole member of GV 2015 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote and dispose of these shares. Each of GV 2015 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
Starco Brands, Inc.
Report date May 15, 2025 · Filed May 19, 2025
Jointly reported with GV 2016 GP, L.L.C., GV 2016 GP, L.P., GV 2016, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy GV 2016, L.P. | 147,490,961 |
Reported balance
After 2025-05-15 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-05-15 · Other · Acquired 47,980,156 · Balance 147,490,961 F1: The Reporting Persons received these securities for no additional consideration, effective May 15, 2025, as a post-closing purchase price adjustment (the "Second Post-Closing Adjustment") under the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 14, 2023, entered into by and among: (i) the Issuer; (ii) Starco Merger Sub I, Inc., a Delaware corporation; (iii) Soylent Nutrition, Inc., a Delaware corporation ("Soylent"); and (iv) Hamilton Start, LLC, solely in its capacity as the representative of the Soylent equityholders, in connection with the February 15, 2023 sale of Soylent to the Issuer, as subsequently modified by that certain Stockholder Agreement (the "Stockholder Agreement") entered into on March 15, 2024, by and between the Issuer and certain Soylent stockholders. F2: Pursuant to the Merger Agreement as amended by the Stockholder Agreement, the 2016 Partnership was entitled to receive additional shares of the Issuer's Class A Common Stock for no additional consideration if the volume weighted average trading price of the Issuer's Class A Common Stock was less than $0.35 per share for each of the 30-trading day periods ending on: (i) February 14, 2024 and (ii) May 15, 2025. The reported transaction represents the release of the Second Post-Closing Adjustment. F3: The securities reported in this row are directly held by GV 2016, L.P. (the "2016 Partnership"). The general partner of the 2016 Partnership is GV 2016 GP, L.P. ("2016 GP"). The general partner of 2016 GP is GV 2016 GP, L.L.C. ("2016 LLC"). The sole managing member of 2016 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole managing member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of 2016 GP, 2016 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2016 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Persons received these securities for no additional consideration, effective May 15, 2025, as a post-closing purchase price adjustment (the "Second Post-Closing Adjustment") under the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 14, 2023, entered into by and among: (i) the Issuer; (ii) Starco Merger Sub I, Inc., a Delaware corporation; (iii) Soylent Nutrition, Inc., a Delaware corporation ("Soylent"); and (iv) Hamilton Start, LLC, solely in its capacity as the representative of the Soylent equityholders, in connection with the February 15, 2023 sale of Soylent to the Issuer, as subsequently modified by that certain Stockholder Agreement (the "Stockholder Agreement") entered into on March 15, 2024, by and between the Issuer and certain Soylent stockholders.
F2: Pursuant to the Merger Agreement as amended by the Stockholder Agreement, the 2016 Partnership was entitled to receive additional shares of the Issuer's Class A Common Stock for no additional consideration if the volume weighted average trading price of the Issuer's Class A Common Stock was less than $0.35 per share for each of the 30-trading day periods ending on: (i) February 14, 2024 and (ii) May 15, 2025. The reported transaction represents the release of the Second Post-Closing Adjustment.
F3: The securities reported in this row are directly held by GV 2016, L.P. (the "2016 Partnership"). The general partner of the 2016 Partnership is GV 2016 GP, L.P. ("2016 GP"). The general partner of 2016 GP is GV 2016 GP, L.L.C. ("2016 LLC"). The sole managing member of 2016 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole managing member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of 2016 GP, 2016 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2016 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Past disclosures · reporting ended (6)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARMO BioSciences, Inc.
Report date January 30, 2018 · Filed January 30, 2018
Jointly reported with GV 2014 GP, L.L.C., GV 2014, L.P.
Section 16 reporting ended · disclosed 2018-01-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GV 2014, L.P. | 607,350 |
Reported balance
After 2018-01-30 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-01-30 · Conversion · Acquired 607,350 · Balance 607,350 F1: The total represents shares received upon conversion of shares of Series C Convertible Preferred Stock. F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F2: The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
| Series C Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy GV 2014, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-01-30 · Conversion · Disposed 607,350 · Balance 0 F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F2: The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The total represents shares received upon conversion of shares of Series C Convertible Preferred Stock.
F2: The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Dianthus Therapeutics, Inc. /DE/
Report date June 25, 2018 · Filed June 27, 2018
Jointly reported with GV 2016 GP, L.L.C., GV 2016 GP, L.P., GV 2016, L.P.
Section 16 reporting ended · disclosed 2018-06-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GV 2016, L.P. | 3,339,137 |
Reported balance
After 2018-06-25 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-06-25 · Conversion · Acquired 3,339,137 · Balance 3,339,137 F1: The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date. F2: The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectBy GV 2016, L.P. | 0 |
Reported balance
After 2018-06-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-06-25 · Conversion · Disposed 133,400 · Balance 0 F1: The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date. F2: The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectBy GV 2016, L.P. | 0 |
Reported balance
After 2018-06-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-06-25 · Conversion · Disposed 8,494,864 · Balance 0 F1: The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date. F2: The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date.
F2: The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
Ethos Technologies Inc.
Report date July 27, 2026 · Filed July 29, 2026
Jointly reported with GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P.
Section 16 reporting ended · disclosed 2026-07-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy GV 2019, L.P. | 2,443,425 |
Last balance in matching sequence
After 2026-07-28 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-07-27 · Other · Disposed 196,931 · Balance 2,561,563 F1: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Row 3 · 2026-07-28 · Other · Disposed 118,138 · Balance 2,443,425 F1: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Alphabet Holdings LLC | 0 |
Reported balance
After 2026-07-27 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-07-27 · Sale · Disposed 196,931 · Balance 0 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.21 to $19.795, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4. F4: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Alphabet Holdings LLC | 0 |
Reported balance
After 2026-07-28 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-07-28 · Sale · Disposed 118,138 · Balance 0 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.45 to $19.19, inclusive. F4: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy GV 2021, L.P. | 571,907 |
Reported balance
Holding disclosure · report date 2026-07-27 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 571,907 F6: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "2021 Partnership"). GV 2021 GP, L.P. (the "2021 GP") is the general partner of the 2021 Partnership. GV 2021 GP, L.L.C. ("GV 2021 LLC") is the general partner of the 2021 GP. Alphabet Holdings is the sole member of GV 2021 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2021 Partnership. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
F2: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.21 to $19.795, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4.
F4: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.45 to $19.19, inclusive.
F6: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "2021 Partnership"). GV 2021 GP, L.P. (the "2021 GP") is the general partner of the 2021 Partnership. GV 2021 GP, L.L.C. ("GV 2021 LLC") is the general partner of the 2021 GP. Alphabet Holdings is the sole member of GV 2021 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2021 Partnership. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
IonQ, Inc.
Report date April 11, 2022 · Filed April 12, 2022
Jointly reported with GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P.
Section 16 reporting ended · disclosed 2022-04-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GV 2019 L.P. | 4,556,532 |
Reported balance
Holding disclosure · report date 2022-04-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,556,532 F1: The reported securities are held directly by GV 2019, L.P. (the "Partnership"). GV 2019 GP, L.P. (the "GP") is the general partner of the Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the GP. Alphabet Holdings LLC ("Alphabet Holdings") is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the sole controlling stockholder of XXVI. Each of the GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are held directly by GV 2019, L.P. (the "Partnership"). GV 2019 GP, L.P. (the "GP") is the general partner of the Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the GP. Alphabet Holdings LLC ("Alphabet Holdings") is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the sole controlling stockholder of XXVI. Each of the GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Verve Therapeutics, Inc.
Report date July 25, 2025 · Filed July 28, 2025
Jointly reported with GV 2017 GP, L.L.C., GV 2017 GP, L.P., GV 2017, L.P., GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2023 GP, L.L.C., GV 2023 GP, L.P., GV 2023, L.P.
Section 16 reporting ended · disclosed 2025-07-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GV 2017 L.P. | 0 |
Reported balance
After 2025-07-25 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-07-25 · Other · Disposed 6,108,442 · Balance 0 F1: In connection with the terms of an Agreement and Plan of Merger, dated as of June 16, 2025 (the "Merger Agreement"), by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock (the "Common Stock"). In exchange for each share, tendering stockholders received: (i) $10.50 per share, net to the stockholder in cash, without interest and less any applicable tax withholding (the "Cash Consideration"); plus (ii) one non-tradable contingent value right (each, a "CVR" and, together with the Cash Consideration, the "Offer Price"), which represents the contractual right to receive a contingent payment of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of a certain specified milestone relating to the Issuer's business, F2: (continued from footnote 1) in accordance with the terms and subject to the conditions and other provisions of a contingent value rights agreement entered into by and among Parent, the Purchaser, and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of July 25, 2025, with the Issuer continuing as the surviving entity and an indirect wholly owned subsidiary of Parent. F3: The securities reported in this row are directly held by GV 2017, L.P. (the "2017 Partnership"). The general partner of the 2017 Partnership is GV 2017 GP, L.P. (the "2017 GP"). The general partner of the 2017 GP is GV 2017 GP, L.L.C. ("GV 2017 LLC"). The sole member of GV 2017 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2017 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy GV 2019 L.P. | 0 |
Reported balance
After 2025-07-25 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-07-25 · Other · Disposed 4,260,047 · Balance 0 F1: In connection with the terms of an Agreement and Plan of Merger, dated as of June 16, 2025 (the "Merger Agreement"), by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock (the "Common Stock"). In exchange for each share, tendering stockholders received: (i) $10.50 per share, net to the stockholder in cash, without interest and less any applicable tax withholding (the "Cash Consideration"); plus (ii) one non-tradable contingent value right (each, a "CVR" and, together with the Cash Consideration, the "Offer Price"), which represents the contractual right to receive a contingent payment of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of a certain specified milestone relating to the Issuer's business, F2: (continued from footnote 1) in accordance with the terms and subject to the conditions and other provisions of a contingent value rights agreement entered into by and among Parent, the Purchaser, and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of July 25, 2025, with the Issuer continuing as the surviving entity and an indirect wholly owned subsidiary of Parent. F4: The securities reported in this row are directly held by GV 2019, L.P. (the "2019 Partnership"). The general partner of the 2019 Partnership is GV 2019 GP, L.P. (the "2019 GP"). The general partner of the 2019 GP is GV 2019 GP, L.L.C. ("GV 2019 LLC"). The sole member of GV 2019 LLC is Alphabet Holdings. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2019 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy GV 2023, L.P. | 0 |
Reported balance
After 2025-07-25 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2025-07-25 · Other · Disposed 1,800,000 · Balance 0 F1: In connection with the terms of an Agreement and Plan of Merger, dated as of June 16, 2025 (the "Merger Agreement"), by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock (the "Common Stock"). In exchange for each share, tendering stockholders received: (i) $10.50 per share, net to the stockholder in cash, without interest and less any applicable tax withholding (the "Cash Consideration"); plus (ii) one non-tradable contingent value right (each, a "CVR" and, together with the Cash Consideration, the "Offer Price"), which represents the contractual right to receive a contingent payment of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of a certain specified milestone relating to the Issuer's business, F2: (continued from footnote 1) in accordance with the terms and subject to the conditions and other provisions of a contingent value rights agreement entered into by and among Parent, the Purchaser, and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of July 25, 2025, with the Issuer continuing as the surviving entity and an indirect wholly owned subsidiary of Parent. F5: The securities reported in this row are directly beneficially owned by GV 2023, L.P. (the "2023 Partnership"). GV 2023 GP, L.P. (the "2023 GP") is the general partner of the 2023 Partnership. GV 2023 GP, L.L.C. ("GV 2023 LLC") is the general partner of the 2023 GP. Alphabet Holdings is the sole member of GV 2023 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2023 GP, GV 2023 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2023 Partnership. Each of the 2023 GP, GV 2023 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the terms of an Agreement and Plan of Merger, dated as of June 16, 2025 (the "Merger Agreement"), by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock (the "Common Stock"). In exchange for each share, tendering stockholders received: (i) $10.50 per share, net to the stockholder in cash, without interest and less any applicable tax withholding (the "Cash Consideration"); plus (ii) one non-tradable contingent value right (each, a "CVR" and, together with the Cash Consideration, the "Offer Price"), which represents the contractual right to receive a contingent payment of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of a certain specified milestone relating to the Issuer's business,
F2: (continued from footnote 1) in accordance with the terms and subject to the conditions and other provisions of a contingent value rights agreement entered into by and among Parent, the Purchaser, and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of July 25, 2025, with the Issuer continuing as the surviving entity and an indirect wholly owned subsidiary of Parent.
F3: The securities reported in this row are directly held by GV 2017, L.P. (the "2017 Partnership"). The general partner of the 2017 Partnership is GV 2017 GP, L.P. (the "2017 GP"). The general partner of the 2017 GP is GV 2017 GP, L.L.C. ("GV 2017 LLC"). The sole member of GV 2017 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2017 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F4: The securities reported in this row are directly held by GV 2019, L.P. (the "2019 Partnership"). The general partner of the 2019 Partnership is GV 2019 GP, L.P. (the "2019 GP"). The general partner of the 2019 GP is GV 2019 GP, L.L.C. ("GV 2019 LLC"). The sole member of GV 2019 LLC is Alphabet Holdings. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2019 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F5: The securities reported in this row are directly beneficially owned by GV 2023, L.P. (the "2023 Partnership"). GV 2023 GP, L.P. (the "2023 GP") is the general partner of the 2023 Partnership. GV 2023 GP, L.L.C. ("GV 2023 LLC") is the general partner of the 2023 GP. Alphabet Holdings is the sole member of GV 2023 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2023 GP, GV 2023 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2023 Partnership. Each of the 2023 GP, GV 2023 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
X4 Pharmaceuticals, Inc
Report date November 20, 2017 · Filed November 20, 2017
Jointly reported with GV 2016 GP, L.L.C., GV 2016 GP, L.P., GV 2016, L.P.
Section 16 reporting ended · disclosed 2017-11-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GV 2016, L.P. | 451,362 |
Reported balance
After 2017-11-20 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-11-20 · Conversion · Acquired 451,362 · Balance 451,362 F1: The shares of Series D Convertible Preferred Stock beneficially owned by the Reporting Persons converted into Common Stock on a 0.29300-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing at the Issuer's initial public offering. The shares had no expiration date. F2: The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
| Series D Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy GV 2016, L.P. | 0 |
Reported balance
After 2017-11-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-11-20 · Conversion · Disposed 1,540,499 · Balance 0 F1: The shares of Series D Convertible Preferred Stock beneficially owned by the Reporting Persons converted into Common Stock on a 0.29300-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing at the Issuer's initial public offering. The shares had no expiration date. F2: The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Series D Convertible Preferred Stock beneficially owned by the Reporting Persons converted into Common Stock on a 0.29300-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing at the Issuer's initial public offering. The shares had no expiration date.
F2: The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 29, 2026 19:28 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 118,138 | $18.90 | $2,232,760.94 |
DisclosureSEC source: 0001168404-26-000041 · form4-07292026_110704.xml · nonDerivative · entry 4 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.45 to $19.19, inclusive. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 28, 2026 Filed Jul 29, 2026 19:28 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 118,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000041 · form4-07292026_110704.xml · nonDerivative · entry 3 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,443,425 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 19:28 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 196,931 | $19.46 | $3,832,848.36 |
DisclosureSEC source: 0001168404-26-000041 · form4-07292026_110704.xml · nonDerivative · entry 2 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.21 to $19.795, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 19:28 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 196,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000041 · form4-07292026_110704.xml · nonDerivative · entry 1 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,561,563 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 24, 2026 Filed Jul 27, 2026 22:21 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 23,417 | $18.88 | $442,000.56 |
DisclosureSEC source: 0001168404-26-000039 · form4-07272026_100703.xml · nonDerivative · entry 4 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $19.40, inclusive. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 24, 2026 Filed Jul 27, 2026 22:21 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 23,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000039 · form4-07272026_100703.xml · nonDerivative · entry 3 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,758,494 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 23, 2026 Filed Jul 27, 2026 22:21 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 63,297 | $19.06 | $1,206,269.92 |
DisclosureSEC source: 0001168404-26-000039 · form4-07272026_100703.xml · nonDerivative · entry 2 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.68 to $19.155, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 23, 2026 Filed Jul 27, 2026 22:21 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 63,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000039 · form4-07272026_100703.xml · nonDerivative · entry 1 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,781,911 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 22, 2026 Filed Jul 23, 2026 20:47 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 49,582 | $19.23 | $953,466.82 |
DisclosureSEC source: 0001168404-26-000036 · form4-07232026_080714.xml · nonDerivative · entry 5 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.02 to $19.445, inclusive. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 22, 2026 Filed Jul 23, 2026 20:47 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 49,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000036 · form4-07232026_080714.xml · nonDerivative · entry 4 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,845,208 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:47 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 200 | $19.72 | $3,944.00 |
DisclosureSEC source: 0001168404-26-000036 · form4-07232026_080714.xml · nonDerivative · entry 3 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:47 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 22,700 | $19.05 | $432,423.65 |
DisclosureSEC source: 0001168404-26-000036 · form4-07232026_080714.xml · nonDerivative · entry 2 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 200 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.72 to $19.715, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:47 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 22,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000036 · form4-07232026_080714.xml · nonDerivative · entry 1 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,894,790 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 20, 2026 Filed Jul 21, 2026 21:11 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 18,386 | $18.87 | $346,859.24 |
DisclosureSEC source: 0001168404-26-000031 · form4-07212026_090748.xml · nonDerivative · entry 4 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.59 to $19.18, inclusive. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 20, 2026 Filed Jul 21, 2026 21:11 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 18,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000031 · form4-07212026_090748.xml · nonDerivative · entry 3 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,917,690 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 17, 2026 Filed Jul 21, 2026 21:11 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 20,534 | $18.68 | $383,614.13 |
DisclosureSEC source: 0001168404-26-000031 · form4-07212026_090748.xml · nonDerivative · entry 2 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.33 to $19.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 5 of this Form 4. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 17, 2026 Filed Jul 21, 2026 21:11 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 20,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000031 · form4-07212026_090748.xml · nonDerivative · entry 1 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,936,076 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 16, 2026 Filed Jul 18, 2026 00:12 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 19,595 | $18.73 | $367,008.47 |
DisclosureSEC source: 0001168404-26-000029 · form4-07182026_120730.xml · nonDerivative · entry 5 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.33 to $19.06 per share, inclusive. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 16, 2026 Filed Jul 18, 2026 00:12 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 19,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000029 · form4-07182026_120730.xml · nonDerivative · entry 4 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,956,610 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 00:12 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 61,992 | $19.84 | $1,229,772.50 |
DisclosureSEC source: 0001168404-26-000029 · form4-07182026_120730.xml · nonDerivative · entry 3 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.38 to $20.03 per share, inclusive. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 00:12 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 12,500 | $18.79 | $234,912.50 |
DisclosureSEC source: 0001168404-26-000029 · form4-07182026_120730.xml · nonDerivative · entry 2 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 61,992 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.30 to $19.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 5 and 6 of this Form 4. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 15, 2026 Filed Jul 18, 2026 00:12 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 74,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000029 · form4-07182026_120730.xml · nonDerivative · entry 1 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 2,976,205 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2026 Filed May 18, 2026 22:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 42,065 | $24.27 | $1,020,829.21 |
DisclosureSEC source: 0001168404-26-000025 · form4-05182026_100553.xml · nonDerivative · entry 5 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.835 to $24.74 per share, inclusive. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2026 Filed May 18, 2026 22:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 45,410 | $23.27 | $1,056,649.83 |
DisclosureSEC source: 0001168404-26-000025 · form4-05182026_100553.xml · nonDerivative · entry 4 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 42,065 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.83 to $23.81 per share, inclusive. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2026 Filed May 18, 2026 22:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 87,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000025 · form4-05182026_100553.xml · nonDerivative · entry 3 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 3,050,697 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 14, 2026 Filed May 18, 2026 22:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 60,077 | $23.01 | $1,382,329.72 |
DisclosureSEC source: 0001168404-26-000025 · form4-05182026_100553.xml · nonDerivative · entry 2 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.81 to $23.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 5 and 6 of this Form 4. F4 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Exchange Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 14, 2026 Filed May 18, 2026 22:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | OtherClass A Common Stock | 60,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001168404-26-000025 · form4-05182026_100553.xml · nonDerivative · entry 1 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 3,138,172 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the GV 2019, L.P. ("2019 Partnership") to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings LLC ("Alphabet Holdings"). The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · ownership.nature: The securities reported in this row are directly beneficially owned by the 2019 Partnership. GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2026 Filed Jan 30, 2026 23:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | ConversionSeries D Preferred Stock · Derivative | 552,126 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001168404-26-000007 · form4-01302026_110152.xml · derivative · entry 8 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2021, L.P. Disclosed balance after: 0 Underlying: Class A Common Stock · 571,907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F4 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "2021 Partnership"). GV 2021 GP, L.P. (the "2021 GP") is the general partner of the 2021 Partnership. GV 2021 GP, L.L.C. ("GV 2021 LLC") is the general partner of the 2021 GP. Alphabet Holdings is the sole member of GV 2021 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2021 Partnership. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2026 Filed Jan 30, 2026 23:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | ConversionSeries C Preferred Stock · Derivative | 3,287,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001168404-26-000007 · form4-01302026_110152.xml · derivative · entry 7 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 0 Underlying: Class A Common Stock · 3,287,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F3 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2019, L.P. (the "2019 Partnership"). GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2026 Filed Jan 30, 2026 23:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | ConversionSeries B Preferred Stock · Derivative | 1,751,791 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001168404-26-000007 · form4-01302026_110152.xml · derivative · entry 6 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2017, L.P. Disclosed balance after: 0 Underlying: Class A Common Stock · 1,755,632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F2 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2017, L.P. (the "2017 Partnership"). GV 2017 GP, L.P. (the "2017 GP") is the general partner of the 2017 Partnership. GV 2017 GP, L.L.C. ("GV 2017 LLC") is the general partner of the 2017 GP. Alphabet Holdings LLC ("Alphabet Holdings") is the sole member of GV 2017 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) the securities directly beneficially owned by the 2017 Partnership. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2026 Filed Jan 30, 2026 23:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 89,676 | $19.00 | $1,703,844.00 |
DisclosureSEC source: 0001168404-26-000007 · form4-01302026_110152.xml · nonDerivative · entry 5 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 3,198,249 F5 · kind: The reported transaction represents a sale of shares of the Issuer's Class A Common Stock by the reporting person as a participant in a secondary offering undertaken in connection with the Issuer's underwritten initial public offering of its Class A Common Stock. F3 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2019, L.P. (the "2019 Partnership"). GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2026 Filed Jan 30, 2026 23:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | SaleClass A Common Stock | 1,755,632 | $19.00 | $33,357,008.00 |
DisclosureSEC source: 0001168404-26-000007 · form4-01302026_110152.xml · nonDerivative · entry 4 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2017, L.P. Disclosed balance after: 0 F5 · kind: The reported transaction represents a sale of shares of the Issuer's Class A Common Stock by the reporting person as a participant in a secondary offering undertaken in connection with the Issuer's underwritten initial public offering of its Class A Common Stock. F2 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2017, L.P. (the "2017 Partnership"). GV 2017 GP, L.P. (the "2017 GP") is the general partner of the 2017 Partnership. GV 2017 GP, L.L.C. ("GV 2017 LLC") is the general partner of the 2017 GP. Alphabet Holdings LLC ("Alphabet Holdings") is the sole member of GV 2017 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) the securities directly beneficially owned by the 2017 Partnership. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2026 Filed Jan 30, 2026 23:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | ConversionClass A Common Stock | 571,907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001168404-26-000007 · form4-01302026_110152.xml · nonDerivative · entry 3 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2021, L.P. Disclosed balance after: 571,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F4 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "2021 Partnership"). GV 2021 GP, L.P. (the "2021 GP") is the general partner of the 2021 Partnership. GV 2021 GP, L.L.C. ("GV 2021 LLC") is the general partner of the 2021 GP. Alphabet Holdings is the sole member of GV 2021 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2021 Partnership. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2026 Filed Jan 30, 2026 23:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | ConversionClass A Common Stock | 3,287,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001168404-26-000007 · form4-01302026_110152.xml · nonDerivative · entry 2 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 3,287,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F3 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2019, L.P. (the "2019 Partnership"). GV 2019 GP, L.P. (the "2019 GP") is the general partner of the 2019 Partnership. GV 2019 GP, L.L.C. ("GV 2019 LLC") is the general partner of the 2019 GP. Alphabet Holdings is the sole member of GV 2019 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the securities directly beneficially owned by the 2019 Partnership. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2026 Filed Jan 30, 2026 23:43 UTC | Ethos Technologies Inc. LIFE · Entity 4157 | ConversionClass A Common Stock | 1,755,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001168404-26-000007 · form4-01302026_110152.xml · nonDerivative · entry 1 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2017, L.P. Disclosed balance after: 1,755,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Series B, Series C, and Series D Preferred Stock were automatically converted into shares of Class A Common Stock of the Issuer pursuant to the Issuer's Amended and Restated Certificate of Incorporation. F2 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2017, L.P. (the "2017 Partnership"). GV 2017 GP, L.P. (the "2017 GP") is the general partner of the 2017 Partnership. GV 2017 GP, L.L.C. ("GV 2017 LLC") is the general partner of the 2017 GP. Alphabet Holdings LLC ("Alphabet Holdings") is the sole member of GV 2017 LLC. XXVI Holdings Inc. ("XXVI") is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) the securities directly beneficially owned by the 2017 Partnership. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:07 UTC | Prime Medicine, Inc. PRME · Entity 5281 | PurchaseCommon Stock | 1,500,000 | $3.30 | $4,950,000.00 |
DisclosureSEC source: 0001415889-25-021025 · form4-08052025_080848.xml · nonDerivative · entry 1 GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2021, L.P. Disclosed balance after: 3,262,440 F1 · kind: Represents shares purchased in connection with an underwritten public offering of the Issuer's Common Stock that closed on August 1, 2025. F2 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "2021 Partnership"). The general partner of the 2021 Partnership is GV 2021 GP, L.P. (the "2021 GP"). The general partner of the 2021 GP is GV 2021 GP, L.L.C. ("GV 2021 LLC"). The sole member of GV 2021 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the securities directly beneficially owned by the 2021 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 17:19 UTC | Verve Therapeutics, Inc. VERV · Entity 11259 | OtherCommon Stock | 1,800,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-020384 · form4-07282025_090715.xml · nonDerivative · entry 3 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2023 GP, L.L.C. · CIK 0001961991 · 10% owner GV 2023 GP, L.P. · CIK 0001961990 · 10% owner GV 2023, L.P. · CIK 0001961979 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2023, L.P. Disclosed balance after: 0 F1 · price: In connection with the terms of an Agreement and Plan of Merger, dated as of June 16, 2025 (the "Merger Agreement"), by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock (the "Common Stock"). In exchange for each share, tendering stockholders received: (i) $10.50 per share, net to the stockholder in cash, without interest and less any applicable tax withholding (the "Cash Consideration"); plus (ii) one non-tradable contingent value right (each, a "CVR" and, together with the Cash Consideration, the "Offer Price"), which represents the contractual right to receive a contingent payment of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of a certain specified milestone relating to the Issuer's business, F2 · price: (continued from footnote 1) in accordance with the terms and subject to the conditions and other provisions of a contingent value rights agreement entered into by and among Parent, the Purchaser, and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of July 25, 2025, with the Issuer continuing as the surviving entity and an indirect wholly owned subsidiary of Parent. F5 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2023, L.P. (the "2023 Partnership"). GV 2023 GP, L.P. (the "2023 GP") is the general partner of the 2023 Partnership. GV 2023 GP, L.L.C. ("GV 2023 LLC") is the general partner of the 2023 GP. Alphabet Holdings is the sole member of GV 2023 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2023 GP, GV 2023 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2023 Partnership. Each of the 2023 GP, GV 2023 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 17:19 UTC | Verve Therapeutics, Inc. VERV · Entity 11259 | OtherCommon Stock | 4,260,047 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-020384 · form4-07282025_090715.xml · nonDerivative · entry 2 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2023 GP, L.L.C. · CIK 0001961991 · 10% owner GV 2023 GP, L.P. · CIK 0001961990 · 10% owner GV 2023, L.P. · CIK 0001961979 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2019 L.P. Disclosed balance after: 0 F1 · price: In connection with the terms of an Agreement and Plan of Merger, dated as of June 16, 2025 (the "Merger Agreement"), by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock (the "Common Stock"). In exchange for each share, tendering stockholders received: (i) $10.50 per share, net to the stockholder in cash, without interest and less any applicable tax withholding (the "Cash Consideration"); plus (ii) one non-tradable contingent value right (each, a "CVR" and, together with the Cash Consideration, the "Offer Price"), which represents the contractual right to receive a contingent payment of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of a certain specified milestone relating to the Issuer's business, F2 · price: (continued from footnote 1) in accordance with the terms and subject to the conditions and other provisions of a contingent value rights agreement entered into by and among Parent, the Purchaser, and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of July 25, 2025, with the Issuer continuing as the surviving entity and an indirect wholly owned subsidiary of Parent. F4 · ownership.nature: The securities reported in this row are directly held by GV 2019, L.P. (the "2019 Partnership"). The general partner of the 2019 Partnership is GV 2019 GP, L.P. (the "2019 GP"). The general partner of the 2019 GP is GV 2019 GP, L.L.C. ("GV 2019 LLC"). The sole member of GV 2019 LLC is Alphabet Holdings. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2019 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 17:19 UTC | Verve Therapeutics, Inc. VERV · Entity 11259 | OtherCommon Stock | 6,108,442 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-020384 · form4-07282025_090715.xml · nonDerivative · entry 1 GV 2017 GP, L.L.C. · CIK 0001733338 · 10% owner GV 2017 GP, L.P. · CIK 0001733339 · 10% owner GV 2017, L.P. · CIK 0001733340 · 10% owner GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2023 GP, L.L.C. · CIK 0001961991 · 10% owner GV 2023 GP, L.P. · CIK 0001961990 · 10% owner GV 2023, L.P. · CIK 0001961979 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2017 L.P. Disclosed balance after: 0 F1 · price: In connection with the terms of an Agreement and Plan of Merger, dated as of June 16, 2025 (the "Merger Agreement"), by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock (the "Common Stock"). In exchange for each share, tendering stockholders received: (i) $10.50 per share, net to the stockholder in cash, without interest and less any applicable tax withholding (the "Cash Consideration"); plus (ii) one non-tradable contingent value right (each, a "CVR" and, together with the Cash Consideration, the "Offer Price"), which represents the contractual right to receive a contingent payment of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of a certain specified milestone relating to the Issuer's business, F2 · price: (continued from footnote 1) in accordance with the terms and subject to the conditions and other provisions of a contingent value rights agreement entered into by and among Parent, the Purchaser, and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of July 25, 2025, with the Issuer continuing as the surviving entity and an indirect wholly owned subsidiary of Parent. F3 · ownership.nature: The securities reported in this row are directly held by GV 2017, L.P. (the "2017 Partnership"). The general partner of the 2017 Partnership is GV 2017 GP, L.P. (the "2017 GP"). The general partner of the 2017 GP is GV 2017 GP, L.L.C. ("GV 2017 LLC"). The sole member of GV 2017 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2017 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 19, 2025 19:09 UTC | Starco Brands, Inc. STCB · Entity 7537 | OtherClass A Common Stock | 47,980,156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-013728 · form4-05192025_110520.xml · nonDerivative · entry 1 GV 2016 GP, L.L.C. · CIK 0001722201 · 10% owner GV 2016 GP, L.P. · CIK 0001722204 · 10% owner GV 2016, L.P. · CIK 0001721789 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2016, L.P. Disclosed balance after: 147,490,961 F1 · kind: The Reporting Persons received these securities for no additional consideration, effective May 15, 2025, as a post-closing purchase price adjustment (the "Second Post-Closing Adjustment") under the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 14, 2023, entered into by and among: (i) the Issuer; (ii) Starco Merger Sub I, Inc., a Delaware corporation; (iii) Soylent Nutrition, Inc., a Delaware corporation ("Soylent"); and (iv) Hamilton Start, LLC, solely in its capacity as the representative of the Soylent equityholders, in connection with the February 15, 2023 sale of Soylent to the Issuer, as subsequently modified by that certain Stockholder Agreement (the "Stockholder Agreement") entered into on March 15, 2024, by and between the Issuer and certain Soylent stockholders. F2 · kind: Pursuant to the Merger Agreement as amended by the Stockholder Agreement, the 2016 Partnership was entitled to receive additional shares of the Issuer's Class A Common Stock for no additional consideration if the volume weighted average trading price of the Issuer's Class A Common Stock was less than $0.35 per share for each of the 30-trading day periods ending on: (i) February 14, 2024 and (ii) May 15, 2025. The reported transaction represents the release of the Second Post-Closing Adjustment. F1 · price: The Reporting Persons received these securities for no additional consideration, effective May 15, 2025, as a post-closing purchase price adjustment (the "Second Post-Closing Adjustment") under the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 14, 2023, entered into by and among: (i) the Issuer; (ii) Starco Merger Sub I, Inc., a Delaware corporation; (iii) Soylent Nutrition, Inc., a Delaware corporation ("Soylent"); and (iv) Hamilton Start, LLC, solely in its capacity as the representative of the Soylent equityholders, in connection with the February 15, 2023 sale of Soylent to the Issuer, as subsequently modified by that certain Stockholder Agreement (the "Stockholder Agreement") entered into on March 15, 2024, by and between the Issuer and certain Soylent stockholders. F2 · price: Pursuant to the Merger Agreement as amended by the Stockholder Agreement, the 2016 Partnership was entitled to receive additional shares of the Issuer's Class A Common Stock for no additional consideration if the volume weighted average trading price of the Issuer's Class A Common Stock was less than $0.35 per share for each of the 30-trading day periods ending on: (i) February 14, 2024 and (ii) May 15, 2025. The reported transaction represents the release of the Second Post-Closing Adjustment. F3 · ownership.nature: The securities reported in this row are directly held by GV 2016, L.P. (the "2016 Partnership"). The general partner of the 2016 Partnership is GV 2016 GP, L.P. ("2016 GP"). The general partner of 2016 GP is GV 2016 GP, L.L.C. ("2016 LLC"). The sole managing member of 2016 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole managing member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of 2016 GP, 2016 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2016 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| February 15, 2024 Filed Feb 13, 2025 16:21 UTC | Starco Brands, Inc. STCB · Entity 7537 | OtherClass A Common Stock | 36,300,393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-003895 · form4-02132025_090212.xml · nonDerivative · entry 2 GV 2016 GP, L.L.C. · CIK 0001722201 · 10% owner GV 2016 GP, L.P. · CIK 0001722204 · 10% owner GV 2016, L.P. · CIK 0001721789 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2016, L.P. Disclosed balance after: 99,510,805 F2 · kind: The shares issuable pursuant to the Working Capital Adjustment and the First Post Closing Adjustment (defined below) were issued on a delayed basis during 2024, retroactive to their respective contractually agreed post-closing adjustment dates. F4 · kind: The Reporting Persons received these securities for no additional consideration, effective February 15, 2024, pursuant to the terms of the Merger Agreement as modified by that certain Stockholder Agreement (the "Stockholder Agreement") entered into on March 15, 2024, by and between the Issuer and certain Soylent stockholders. Pursuant to the Merger Agreement as amended by the Stockholder Agreement, the 2016 Partnership is or was entitled to receive additional shares of the Issuer's Class A Common Stock for no additional consideration if the volume weighted average trading price of the Issuer's Class A Common Stock is less than $0.35 per share for each of the 30-trading day periods ending on: (i) February 14, 2024 (the "First Post-Closing Adjustment") and (ii) May 15, 2025 (the "Second Post-Closing Adjustment"). F2 · price: The shares issuable pursuant to the Working Capital Adjustment and the First Post Closing Adjustment (defined below) were issued on a delayed basis during 2024, retroactive to their respective contractually agreed post-closing adjustment dates. F4 · price: The Reporting Persons received these securities for no additional consideration, effective February 15, 2024, pursuant to the terms of the Merger Agreement as modified by that certain Stockholder Agreement (the "Stockholder Agreement") entered into on March 15, 2024, by and between the Issuer and certain Soylent stockholders. Pursuant to the Merger Agreement as amended by the Stockholder Agreement, the 2016 Partnership is or was entitled to receive additional shares of the Issuer's Class A Common Stock for no additional consideration if the volume weighted average trading price of the Issuer's Class A Common Stock is less than $0.35 per share for each of the 30-trading day periods ending on: (i) February 14, 2024 (the "First Post-Closing Adjustment") and (ii) May 15, 2025 (the "Second Post-Closing Adjustment"). F3 · ownership.nature: The securities reported in this row are directly held by GV 2016, L.P. (the "2016 Partnership"). The general partner of the 2016 Partnership is GV 2016 GP, L.P. ("2016 GP"). The general partner of 2016 GP is GV 2016 GP, L.L.C. ("2016 LLC"). The sole managing member of 2016 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole managing member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of 2016 GP, 2016 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2016 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| February 14, 2024 Filed Feb 13, 2025 16:21 UTC | Starco Brands, Inc. STCB · Entity 7537 | OtherClass A Common Stock | 5,675,399 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-003895 · form4-02132025_090212.xml · nonDerivative · entry 1 GV 2016 GP, L.L.C. · CIK 0001722201 · 10% owner GV 2016 GP, L.P. · CIK 0001722204 · 10% owner GV 2016, L.P. · CIK 0001721789 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By GV 2016, L.P. Disclosed balance after: 63,210,412 F1 · kind: The Reporting Persons received these securities for no additional consideration, effective February 14, 2024, as a post-closing working capital adjustment (the "Working Capital Adjustment") under the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 14, 2023, entered into by and among: (i) the Issuer; (ii) Starco Merger Sub I, Inc., a Delaware corporation; (iii) Soylent Nutrition, Inc., a Delaware corporation ("Soylent"); and (iv) Hamilton Start, LLC, solely in its capacity as the representative of the Soylent equityholders, in connection with the February 15, 2023 sale of Soylent to the Issuer. F2 · kind: The shares issuable pursuant to the Working Capital Adjustment and the First Post Closing Adjustment (defined below) were issued on a delayed basis during 2024, retroactive to their respective contractually agreed post-closing adjustment dates. F1 · price: The Reporting Persons received these securities for no additional consideration, effective February 14, 2024, as a post-closing working capital adjustment (the "Working Capital Adjustment") under the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated February 14, 2023, entered into by and among: (i) the Issuer; (ii) Starco Merger Sub I, Inc., a Delaware corporation; (iii) Soylent Nutrition, Inc., a Delaware corporation ("Soylent"); and (iv) Hamilton Start, LLC, solely in its capacity as the representative of the Soylent equityholders, in connection with the February 15, 2023 sale of Soylent to the Issuer. F2 · price: The shares issuable pursuant to the Working Capital Adjustment and the First Post Closing Adjustment (defined below) were issued on a delayed basis during 2024, retroactive to their respective contractually agreed post-closing adjustment dates. F3 · ownership.nature: The securities reported in this row are directly held by GV 2016, L.P. (the "2016 Partnership"). The general partner of the 2016 Partnership is GV 2016 GP, L.P. ("2016 GP"). The general partner of 2016 GP is GV 2016 GP, L.L.C. ("2016 LLC"). The sole managing member of 2016 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole managing member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of 2016 GP, 2016 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2016 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 16:30 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 255,092 | $8.08 | $2,061,398.45 |
DisclosureSEC source: 0000929638-23-002316 · form4.xml · nonDerivative · entry 3 Alphabet Inc. · CIK 0001652044 · 10% owner Alphabet Holdings LLC · CIK 0001847337 · 10% owner CapitalG 2015 LP · CIK 0001771167 · 10% owner CapitalG 2015 GP LLC · CIK 0001779431 · 10% owner CapitalG LP · CIK 0001678225 · 10% owner CapitalG GP LLC · CIK 0001678226 · 10% owner GV 2014 GP, L.L.C. · CIK 0001728736 · 10% owner GV 2014, L.P. · CIK 0001728797 · 10% owner Verily Life Sciences LLC · CIK 0001848282 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F4 · ownership.nature: These shares are owned directly by Verily Life Sciences LLC. OB Technology Holdings Inc., the managing member of Verily Life Sciences LLC, XXVI Holdings Inc., the managing member of OB Technology Holdings Inc., and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of OB Technology Holdings Inc., XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 16:30 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 525,470 | $8.08 | $4,246,323.07 |
DisclosureSEC source: 0000929638-23-002316 · form4.xml · nonDerivative · entry 2 Alphabet Inc. · CIK 0001652044 · 10% owner Alphabet Holdings LLC · CIK 0001847337 · 10% owner CapitalG 2015 LP · CIK 0001771167 · 10% owner CapitalG 2015 GP LLC · CIK 0001779431 · 10% owner CapitalG LP · CIK 0001678225 · 10% owner CapitalG GP LLC · CIK 0001678226 · 10% owner GV 2014 GP, L.L.C. · CIK 0001728736 · 10% owner GV 2014, L.P. · CIK 0001728797 · 10% owner Verily Life Sciences LLC · CIK 0001848282 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,180,474 F1 · price: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F3 · ownership.nature: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 16:30 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 5,719,438 | $8.08 | $46,218,778.48 |
DisclosureSEC source: 0000929638-23-002316 · form4.xml · nonDerivative · entry 1 Alphabet Inc. · CIK 0001652044 · 10% owner Alphabet Holdings LLC · CIK 0001847337 · 10% owner CapitalG 2015 LP · CIK 0001771167 · 10% owner CapitalG 2015 GP LLC · CIK 0001779431 · 10% owner CapitalG LP · CIK 0001678225 · 10% owner CapitalG GP LLC · CIK 0001678226 · 10% owner GV 2014 GP, L.L.C. · CIK 0001728736 · 10% owner GV 2014, L.P. · CIK 0001728797 · 10% owner Verily Life Sciences LLC · CIK 0001848282 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 15,625,310 F1 · price: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F2 · ownership.nature: These shares are owned directly by Alphabet Holdings LLC. XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 21:03 UTC | Prime Medicine, Inc. PRME · Entity 5281 | SaleCommon Stock | 19,003 | $14.97 | $284,495.81 |
DisclosureSEC source: 0001209191-23-039122 · doc4.xml · nonDerivative · entry 4 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F3 · kind: This transaction was entered into pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 6, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.78 to $15.09, inclusive. F5 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 21:03 UTC | Prime Medicine, Inc. PRME · Entity 5281 | OtherCommon Stock | 19,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039122 · doc4.xml · nonDerivative · entry 3 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 10,100,058 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the 2019 Partnership to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings. The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended, and pursuant to a Rule 10b5-1 plan adopted by the 2019 Partnership on April 6, 2023. F2 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2019, L.P. (the "2019 Partnership"). The general partner of the 2019 Partnership is GV 2019 GP, L.P. (the "2019 GP"). The general partner of the 2019 GP is GV 2019 GP, L.L.C. ("GV 2019 LLC"). The sole member of GV 2019 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Act")) the securities directly beneficially owned by the 2019 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:03 UTC | Prime Medicine, Inc. PRME · Entity 5281 | SaleCommon Stock | 37,405 | $15.06 | $563,248.23 |
DisclosureSEC source: 0001209191-23-039122 · doc4.xml · nonDerivative · entry 2 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F3 · kind: This transaction was entered into pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 6, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.90 to $15.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 4 and in footnote 6 of this Form 4. F5 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:03 UTC | Prime Medicine, Inc. PRME · Entity 5281 | OtherCommon Stock | 37,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039122 · doc4.xml · nonDerivative · entry 1 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By GV 2019, L.P. Disclosed balance after: 10,119,061 F1 · kind: The reported transaction represents a pro rata in-kind distribution, for no consideration, by the 2019 Partnership to its partners, which resulted in all of the securities reported in Column 4 of this row being distributed to the direct ownership of the 2019 Partnership's affiliate, Alphabet Holdings. The aforementioned distribution was made in accordance with the exemptions afforded pursuant to Rules 16a-13 and/or 16a-9 promulgated under the Securities Exchange Act of 1934, as amended, and pursuant to a Rule 10b5-1 plan adopted by the 2019 Partnership on April 6, 2023. F2 · ownership.nature: The securities reported in this row are directly beneficially owned by GV 2019, L.P. (the "2019 Partnership"). The general partner of the 2019 Partnership is GV 2019 GP, L.P. (the "2019 GP"). The general partner of the 2019 GP is GV 2019 GP, L.L.C. ("GV 2019 LLC"). The sole member of GV 2019 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Act")) the securities directly beneficially owned by the 2019 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 20:17 UTC | Prime Medicine, Inc. PRME · Entity 5281 | SaleCommon Stock | 6,532 | $15.02 | $98,109.33 |
DisclosureSEC source: 0001209191-23-038363 · doc4.xml · nonDerivative · entry 4 GV 2019 GP, L.L.C. · CIK 0001845038 · 10% owner GV 2019 GP, L.P. · CIK 0001845039 · 10% owner GV 2019, L.P. · CIK 0001845041 · 10% owner GV 2021 GP, L.L.C. · CIK 0001861206 · 10% owner GV 2021 GP, L.P. · CIK 0001861216 · 10% owner GV 2021, L.P. · CIK 0001861202 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By Alphabet Holdings LLC Disclosed balance after: 0 F3 · kind: This transaction was entered into pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 6, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.95 to $15.13, inclusive. F5 · ownership.nature: The securities reported in this row were directly beneficially owned by Alphabet Holdings at the time of sale. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of XXVI and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Act) securities directly beneficially owned by Alphabet Holdings. Each of the aforementioned entities disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.